Accessibility Menu
Accendra Health logo

Accendra Health(NYSE) OMI

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1983)+30%
5 Year-93%
1 Year-59%
1 Month-3%
N/A
Accendra Health last closing stock price
MetricPriceDate
Last closeUSD 3.252026-07-28
Accendra Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.97%USD 3.422026-07-21
1 month-2.69%USD 3.342026-06-26
3 month-6.88%USD 3.492026-04-29
Year to date+16.07%USD 2.802025-12-31
1 year-58.7%USD 7.872025-07-28
3 year-82.35%USD 18.412023-07-28
5 year-92.92%USD 45.892021-07-29
Since inception+30.18%USD 2.501983-09-20

Accendra Health Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$402.34M

Net Income (TTM)

-$1.08B

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Oct 30, 2025

OMI News

Foolcom-Featured.png

Owens and Minor Misses Fiscal Q2 Targets

Motley Fool Markets TeamAug 11, 2025
GettyImages-1346675584

Why Owens & Minor Shares Plummeted 32.4% This Week

James HalleyOct 14, 2022
Arrow angles up on a green stock chart

Why Owens & Minor Stock Popped 15% Today

Rich SmithNov 3, 2021
Woman wearing protective mask

Why Owens & Minor Stock Is Tumbling Today

Keith SpeightsAug 3, 2021
Happy man with laptop

3 Red-Hot Stocks That Are Still Dirt Cheap

Keith SpeightsJul 25, 2021
Arrow angles up on a green stock chart

Why Owens & Minor Stock Soared More Than 25% Today

Rich SmithMay 26, 2021
Doctor wearing gloves and mask

Why Owens & Minor Stock Is Skyrocketing Today

Keith SpeightsFeb 24, 2021
Red arrow goes down and green arrow goes up

Why Owens & Minor Stock Dropped 7% Today

Rich SmithDec 16, 2020
Page 1

OMI: Motley Fool Moneyball Superscore

26

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Accendra Health

Accendra Health helps people manage their medical needs from the comfort of home. It provides essential equipment for chronic conditions like diabetes and sleep apnea. These tools help patients stay out of the hospital while getting care.

What is in the Medical Kit?

  • Diabetes: Equipment and supplies for blood sugar management; accounted for $185.8 million of net revenue in Q1 2026.
  • Sleep therapy: Devices used to treat obstructive sleep apnea; represented $166.9 million of net revenue in Q1 2026.
  • Home respiratory therapy: Oxygen and ventilation support for home use; generated $97.2 million of net revenue in Q1 2026.
  • Chronic care supplies: Products for ostomy, wound care, urology, and incontinence needs; combined categories represented $120.5 million of net revenue in Q1 2026.

New Deals and Divestitures

  • Sold the Products and Healthcare Services segment to Dominion Healthcare Acquisition Corporation on December 31, 2025, for $375 million.
  • Terminated a planned acquisition of Rotech Healthcare Holdings Inc. during the first quarter of 2025.
  • Announced a Balance Sheet Optimization Transaction on May 11, 2026, to extend debt maturities through 2032 and 2033.
  • Authorized a $100 million share repurchase program in February 2025 to buy back common stock through 2027.

Why Accendra Stays Competitive

The company uses capitation arrangements to provide healthcare services at fixed monthly rates for covered members. This model ensures steady service for multi-facility healthcare networks and independent surgery centers nationwide.

The Quarterly Performance Check

  • Net revenue reached $627.8 million in Q1 2026, down 6.8% from Q1 2025 after a major contract ended.
  • Net loss hit $6.5 million in Q1 2026, an improvement from the $25.0 million loss reported in Q1 2025.
  • Operating income hit $17.1 million in Q1 2026, down 13.5% from $19.8 million in Q1 2025.
  • Interest expense reached $32.3 million in Q1 2026, up 33.6% year-over-year following changes in debt allocation.
  • Free cash flow hit a loss of $2.0 million in Q1 2026, worsened from a $35.6 million gain in Q1 2025.

Bottom Line

Accendra Health has transformed from a broad distributor into a specialized provider of direct-to-patient home healthcare services. The company now focuses on managing chronic conditions through home-based equipment and specialized medical supplies.

AI Generated • May 20, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

6,500

CEO

Edward A. Pesicka, MBA, CPA

Website

www.owens-minor.com

Headquarters

Mechanicsville, VA 23116, US

OMI Financials

Key Financial Metrics (TTM)

Gross Margin

45.95%

Operating Margin

6.91%

Net Income Margin

-39.84%

Return on Equity

264.54%

Return on Capital

N/A

Return on Assets

-44.79%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$253.66M

Operating Income

$44.46M

EBITDA

$255.16M

Operating Cash Flow

-$201.50M

Capital Expenditure

$20.41M

Free Cash Flow

-$181.09M

Cash & ST Invst.

$336.88M

Total Debt

$648.72M

Accendra Health Performance Analysis

Accendra Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 9,955,475,0001.7%
20232023-12-31USD 10,333,967,0003.8%
20242024-12-31USD 2,680,112,000-74.1%
20252025-12-31USD 2,762,032,0003.1%
Accendra Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-74.1%
Q32025-09-302.3%
Q42025-12-31-279.2%
Q12026-03-31121.8%
Accendra Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.29-90.0%
20232023-12-31USD -0.55N/A
20242024-12-31USD -4.73767.2%
20252025-12-31USD -14.31202.9%
Accendra Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-3431.3%
Q32025-09-3082.8%
Q42025-12-31796.4%
Q12026-03-31-100.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$272.35M

-89.7%

Gross Profit

$272.35M

-48.2%

Gross Margin

100.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

23,200

N/A

Net Income

-$6.47M

+74.1%

EBITDA

$78.87M

+31.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$336.88M

+466.8%

Total Debt

$648.72M

-71.4%

Accounts Receivable

$103.70M

-82.1%

Inventory

$65.29M

-95.4%

Long Term Debt

$67.47M

-97.0%

Short Term Debt

$581.25M

+1064.8%

Return on Assets

-44.79%

N/A

Return on Invested Capital

15.47%

N/A

Free Cash Flow

$72.00M

+172.2%

Operating Cash Flow

$0.00

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SGHTSight Sciences, Inc.
$5.34+0.75%
OMOutset Medical, Inc.
$4.66-1.27%
CVRXCVRx, Inc.
$4.95+0.00%
ACRSAclaris Therapeutics, Inc.
$5.12-3.94%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$8.41-0.06%
TAT&T
$23.94-0.03%
SMRNuScale Power
$7.59-0.08%
ORCLOracle
$117.74-0.02%

Questions About OMI

What is the current price of Accendra Health?

Accendra Health is trading at N/A per share.

What is the 52-week range for Accendra Health?

Over the past 52 weeks, Accendra Health has traded between N/A and N/A.

How much debt does Accendra Health have?

As of the most recent reporting period, Accendra Health reported total debt of $2.17B.

How much cash does Accendra Health have on hand?

Accendra Health reported $336.88M in cash and cash equivalents in its most recent financial results.

What is Accendra Health’s dividend yield?

Accendra Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services